Nura Bio Closes Series A Financing, Raising $140+ Million In Total Funding
17 Sep 2024 //
BUSINESSWIRE
Nura Bio Initiates Ph I Trial for Oral, Brain-Penetrant SARM1 Inhibitor, NB-4746
25 Aug 2023 //
BUSINESSWIRE
Nura Reports Data Validating Conserved Mechanism of Inhibition of NAD Hydrolases
13 Sep 2022 //
BUSINESSWIRE